Research map: Spatially resolved transcriptomic profiling of myelofibrosis spleen reveals compartment specific niche programs

Back to the article

Papers in this map

  1. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing · Yoav Benjamini · 1995 · 112507 citations · Cited by this paper
  2. Cystathionine beta-synthase promotes anoikis resistance and transcoelomic metastasis in ovarian cancer via SP1- ITGB1 regulation · 2026 · Related
  3. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms · Joseph David Khoury · 2022 · 4220 citations · Cited by this paper
  4. Role of methionine metabolism in cancer: recent advances in molecular mechanisms and therapeutic implications · 2026 · Related
  5. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data · Daniel A. Arber · 2022 · 2919 citations · Cited by this paper
  6. Single-cell profiling reveals reprogrammed hierarchy and disrupted immune-stromal ecosystem in TP53-mutated AML · 2026 · Related
  7. Primary myelofibrosis: 2023 update on diagnosis, risk‐stratification, and management · Ayalew Tefferi · 2023 · 304 citations · Cited by this paper
  8. Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinoma · 2026 · Related
  9. A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression · Caroline Marty · 2013 · 196 citations · Cited by this paper
  10. Novel non-viral in vivo CAR-T therapies: latest updates from the 2025 ASH annual meeting · 2026 · Related
  11. Integrin-Dependent Cell–Matrix Adhesion in Endothelial Health and Disease · Jurjan Aman · 2023 · 125 citations · Cited by this paper
  12. Stem cell engineering for the generation of allogeneic CAR-directed natural killer T cells targeting endometrial carcinoma · 2026 · Related
  13. Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis · Benedetta Gaia Erba · 2017 · 29 citations · Cited by this paper
  14. Methods and applications of patient-derived organoid models for immune microenvironment and immunotherapy research in multiple cancer types · 2026 · Related
  15. Inflammatory stromal and T cells mediate human bone marrow niche remodeling in clonal hematopoiesis and myelodysplasia · Karin D. Prummel · 2025 · 20 citations · Cited by this paper
  16. Functional xenogeneic hematopoietic cells maintaining donor-dominant identity and immune tolerance enable therapy · 2026 · Related
  17. Evolution of WHO diagnostic criteria in “Classical Myeloproliferative Neoplasms” compared with the International Consensus Classification · Jürgen Thiele · 2025 · 19 citations · Cited by this paper
  18. Targeting epigenetic methylation: emerging diagnosis and therapeutic strategies in cancer · 2026 · Related
  19. The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells · Maria Antonietta Avanzini · 2018 · 15 citations · Cited by this paper
  20. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms · Hans Carl Hasselbalch · 2023 · 14 citations · Cited by this paper
  21. The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis · Marco Pizzi · 2016 · 13 citations · Cited by this paper

Source: OpenAlex (CC0)